Lingxiao Zhang
- Immunology top 5%
- Immune cells in cancer 9
- Immunotherapy and Immune Responses 8
- Cancer Research top 5%
- Breast Cancer Treatment Studies 7
- Biomaterials top 5%
- Pollution top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 17
-
- RNA Interference and Gene Delivery 8
-
- Alzheimer's disease research and treatments 7
-
- Neuroinflammation and Neurodegeneration Mechanisms 7
-
- Peptidase Inhibition and Analysis 6
- Co-authors
- Rui‐tian LiuZhi Ping XuRama NatarajanXiwei WuYingbo JiaMiao FengFang‐Jie ZhaoDong‐qun Liu
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Lingxiao Zhang
135 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Immunology 541
- Cancer Research 381
- Biomaterials 294
- Pollution 233
- Biomedical Engineering 861
Countries citing papers authored by Lingxiao Zhang
This map shows the geographic impact of Lingxiao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxiao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxiao Zhang more than expected).
Fields of papers citing papers by Lingxiao Zhang
This network shows the impact of papers produced by Lingxiao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxiao Zhang. The network helps show where Lingxiao Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingxiao Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 31 | |
| 16 | 2020 | 66 | |
| 17 | 2019 | 36 | |
| 18 | 2019 | 144 | |
| 19 | 2018 | 93 | |
| 20 | 2017 | 107 |
About Lingxiao Zhang
Lingxiao Zhang is a scholar working on Immunology, Cancer Research and Oncology, having authored 144 papers that have together received 3.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (17 papers), Immune cells in cancer (9 papers), RNA Interference and Gene Delivery (8 papers), Immunotherapy and Immune Responses (8 papers), Breast Cancer Treatment Studies (7 papers), Alzheimer's disease research and treatments (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Immunology (541 citations), Cancer Research (381 citations) and Biomaterials (294 citations). Lingxiao Zhang has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Rui‐tian Liu, Zhi Ping Xu, Rama Natarajan, Xiwei Wu, Yingbo Jia, Miao Feng, Fang‐Jie Zhao, Dong‐qun Liu, Tamar Seideman and Arthur D. Riggs. Their work appears in journals such as Cell, Advanced Materials and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.